Abstract
Background Smoking is a major preventable cause of morbidity and mortality. We assessed smoking behaviour in 6-17-year-olds. In 13-17-year-olds, we studied risk factors for smoking and compared the frequency of respiratory problems between those who smoked and those who did not.
Methods We used data from LuftiBus in the school, a school-based survey of the respiratory health of children carried out 2013-2016 in the canton of Zurich, Switzerland. Participants were asked about cigarette, shisha, and electronic smoking device (ESD) smoking, and respiratory symptoms and diseases. We studied the association between smoking and risk factors using logistic regression.
Results We included 3488 schoolchildren with data on active smoking. Five percent of the 6-12-year-olds (90 of 1905) had smoked occasionally (<once/week). Among 13-17-year-olds (N=1583), 563 (36%) had smoked occasionally of whom 414 smoked ESDs, 409 shishas, and 276 cigarettes. Among 54 (3%) 13-17-year-olds who smoked frequently (≥once/week), 41 (76%) smoked cigarettes, and 22% of 15-17-year-olds (104/477) had smoked all three products. Smoking was more common in adolescents who were male, lived in rural areas, and whose mother (adjusted OR 1.7, 95% CI 1.3 - 2.3) or father (aOR 1.5, 95% CI 1.2 – 1.9) smoked. Respiratory symptoms in the past year such as rhinitis, dyspnoea, and wheeze were more common in adolescents who smoked frequently or occasionally than in never smokers.
Conclusion Smoking of shishas and ESDs is popular among Swiss adolescents and often combined with smoking cigarettes. Structural smoking prevention strategies should include all forms of smoking including shishas and ESDs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by Lunge Zuerich, Switzerland.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of the canton of Zurich approved the study (KEK-ZH-Nr: 2014-0491).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The LuftiBus in the school dataset is available on reasonable request by contacting Alexander Moeller by email: alexander.moeller{at}kispi.uzh.ch
